Radiation Therapy, Temozolomide, and Irinotecan in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in
chemotherapy, such as temozolomide and irinotecan, work in different ways to stop tumor cells
from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may
kill more tumor cells.
PURPOSE: This phase II trial is studying how well radiation therapy, temozolomide, and
irinotecan work in treating patients with newly diagnosed glioblastoma multiforme.